BROWSE RESULT OF O

11 Records

 

Record No:1


ACCESS NO100598
GENEORM1
DESCRIPTIONOrosomucoid 1
NCBI ENTREZ ACCESS NO5004
UNIPROT ACCESS NOP02763
ORGANISMHuman
DISEASE PHENOTYPEAsthma
SAMPLEBroncho Alveolar Lavage (BAL)F
TECHNIQUESLC-MS/MS
OMICSProteomics
STUDY High Throughput
COMMENTSAn acute phase protein.
GEO_PRIDE_ACCESS_NON/A
REFERENCE15951573
DRUG TARGETBE0000925
MONCLONAL ANTIBODYAnti-Alpha 1 acid Glycoprotein for Human


Record No:2


ACCESS NO100624
GENEORM1
DESCRIPTIONOrosomucoid 1
NCBI ENTREZ ACCESS NO5004
UNIPROT ACCESS NOP02763
ORGANISMHuman
DISEASE PHENOTYPESeasonal allergic rhinitis(Patients treated with glucocorticoids for biomarker identification)
SAMPLENasal fluid
TECHNIQUESQuantitative proteomic analysis through LC/MSMS an
OMICSProteomics
STUDY High Throughput and Low Throughput
COMMENTSORM is a serum protein which is synthesised by the liver as well as epithelial cells and macrophages. It exerts immunomodulatory action during acute phase immune response and is significantly decreased after glucocorticoid treatment
GEO_PRIDE_ACCESS_NON/A
REFERENCE21887273
DRUG TARGETBE0000925
MONCLONAL ANTIBODYAnti-Alpha 1 Acid Glycoprotein for Human


Record No:3


ACCESS NO100625
GENEORM2
DESCRIPTIONOrosomucoid 2
NCBI ENTREZ ACCESS NO5005
UNIPROT ACCESS NOP19652
ORGANISMHuman
DISEASE PHENOTYPESeasonal allergic rhinitis(Patients treated with glucocorticoids for biomarker identification)
SAMPLENasal fluid
TECHNIQUESQuantitative proteomic analysis through LC/MSMS an
OMICSProteomics
STUDY High Throughput and Low Throughput
COMMENTSORM is a serum protein which is synthesised by the liver as well as epithelial cells and macrophages. It exerts immunomodulatory action during acute phase immune response and is significantly decreased after glucocorticoid treatment
GEO_PRIDE_ACCESS_NON/A
REFERENCE21887273
DRUG TARGET
MONCLONAL ANTIBODYN/A


Record No:4


ACCESS NO100936
GENEOvgp1
DESCRIPTIONOviductal glycoprotein 1
NCBI ENTREZ ACCESS NO12659
UNIPROT ACCESS NOQ62010
ORGANISMBALB/C mice
DISEASE PHENOTYPEFood allergy caused by Beta lactoglobulin Ovalbumin and peanut agglutinin
SAMPLEMesenteric lymph node
TECHNIQUEScDNA microarray
OMICSGenomics
STUDY High Throughput
COMMENTSDownregulated after induction with food allergen challenge.
GEO_PRIDE_ACCESS_NON/A
REFERENCE21211037
DRUG TARGET
MONCLONAL ANTIBODYN/A


Record No:5


ACCESS NO101018
GENEORM1
DESCRIPTIONOrosomucoid 1
NCBI ENTREZ ACCESS NO5004
UNIPROT ACCESS NOP02763
ORGANISMHuman
DISEASE PHENOTYPEAsthma with eosinophilic and neutrophilic inflammation
SAMPLESputum
TECHNIQUESMicroarray and qPCR
OMICSGenomics
STUDY High Throughput and Low Throughput
COMMENTSIt shows highest expression in patients with neutrophilic asthma.
GEO_PRIDE_ACCESS_NON/A
REFERENCE24582314
DRUG TARGET
MONCLONAL ANTIBODYAnti-Alpha 1 Acid Glycoprotein for Human


Record No:6


ACCESS NO101458
GENEOrm1
DESCRIPTIONOrosomucoid 1
NCBI ENTREZ ACCESS NO18405
UNIPROT ACCESS NOQ60590
ORGANISMFemale BALB/c mice
DISEASE PHENOTYPEAllergic asthma (Immunological charecterization after exposure to Metarhizium anisopliae(MACA)compar
SAMPLELung Tissue
TECHNIQUESMicroarray
OMICSGenomics
STUDY High Throughput
COMMENTSUpregulated after 3 and 12 hours of fungal allergen induction in asthmatic mice.
GEO_PRIDE_ACCESS_NON/A
REFERENCE20045013
DRUG TARGETBE0000925
MONCLONAL ANTIBODYN/A


Record No:7


ACCESS NO101491
GENEOas3
DESCRIPTION2'-5' oligoadenylate synthetase 3
NCBI ENTREZ ACCESS NO246727
UNIPROT ACCESS NOQ8VI93
ORGANISMFemale BALB/c mice
DISEASE PHENOTYPEAllergic asthma (Immunological charecterization after exposure to Metarhizium anisopliae(MACA)compar
SAMPLELung Tissue
TECHNIQUESMicroarray
OMICSGenomics
STUDY High Throughput
COMMENTSUpregulated after 3 and 12 hours of allergen induction in asthmatics.
GEO_PRIDE_ACCESS_NON/A
REFERENCE20045013
DRUG TARGET
MONCLONAL ANTIBODYN/A


Record No:8


ACCESS NO101700
GENEOGN
DESCRIPTIONMimecan (osteoglycin) (osteoinductive factor)
NCBI ENTREZ ACCESS NO4969
UNIPROT ACCESS NOP20774
ORGANISMHuman
DISEASE PHENOTYPEAsthma induced by allergen challenge
SAMPLEBroncho Alveolar Lavage (BAL) Fluid
TECHNIQUESLC-MS/MS
OMICSProteomics
STUDY High Throughput
COMMENTSThis growth factor is up regulated in allergic asthma.
GEO_PRIDE_ACCESS_NON/A
REFERENCE15951573
DRUG TARGET
MONCLONAL ANTIBODYAnti-OIF [EPR6963] for Human


Record No:9


ACCESS NO101770
GENEORM1
DESCRIPTIONOrosomucoid 1
NCBI ENTREZ ACCESS NO5004
UNIPROT ACCESS NOP02763
ORGANISMHuman
DISEASE PHENOTYPEAsthma induced by allergen challenge
SAMPLEBroncho Alveolar Lavage (BAL) Fluid
TECHNIQUESLC-MS/MS
OMICSProteomics
STUDY High Throughput
COMMENTSThis acute phase protein is up regulated in allergic asthma.
GEO_PRIDE_ACCESS_NON/A
REFERENCE15951573
DRUG TARGETBE0000925
MONCLONAL ANTIBODYAnti-Alpha 1 Acid Glycoprotein for Human


Record No:10


ACCESS NO101839
GENEOSCAR
DESCRIPTIONOsteoclast-associated receptor hOSCAR-M1
NCBI ENTREZ ACCESS NO126014
UNIPROT ACCESS NOQ8IYS5
ORGANISMHuman
DISEASE PHENOTYPEAsthma induced by allergen challenge
SAMPLEBroncho Alveolar Lavage (BAL) Fluid
TECHNIQUESLC-MS/MS
OMICSProteomics
STUDY High Throughput
COMMENTSThis protein is down regulated in allergic asthma.
GEO_PRIDE_ACCESS_NON/A
REFERENCE15951573
DRUG TARGET
MONCLONAL ANTIBODYN/A


Record No:11


ACCESS NO101878
GENEOPTN
DESCRIPTIONOptineurin
NCBI ENTREZ ACCESS NO10133
UNIPROT ACCESS NOQ96CV9
ORGANISMHuman
DISEASE PHENOTYPEAtopic dermatitis
SAMPLEFibroblast
TECHNIQUES2D-PAGE and MALDI-TOF/TOF and Semi qPCR
OMICSProteomics
STUDY High Throughput and Low Throughput
COMMENTSThis protein is upregulated in atopic fibroblasts comparative to normal fibroblasts.
GEO_PRIDE_ACCESS_NON/A
REFERENCE15468290
DRUG TARGET
MONCLONAL ANTIBODYN/A